Terug
Dagbereik
€ 12,50
€ 16,60
52-Weeksbereik
€ 8,87
€ 16,61
Volume
1.000
50D / 200D Gem.
€ 15,46
/
€ 13,20
Vorige Slotkoers
€ 16,60
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 30,7 | 0,4 |
| P/B | 3,1 | 2,9 |
| ROE % | 10,7 | 3,7 |
| Net Margin % | 7,4 | 3,9 |
| Rev Growth 5Y % | 0,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,84
€ 0,83 – € 0,85
|
670 M | 1 |
| FY2026 |
€ 0,77
€ 0,76 – € 0,78
|
630 M | 1 |
Belangrijkste Punten
Revenue grew 0,83% annually over 5 years — modest growth
Earnings declined -15,92% over the past year
ROE of 10,68% — decent returns on equity
Debt/Equity of 0,09 — conservative balance sheet
Generating 73,61M in free cash flow
P/E of 30,66 — premium valuation
Groei
Revenue Growth (5Y)
0,83%
Revenue (1Y)4,38%
Earnings (1Y)-15,92%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
10,68%
ROIC12,53%
Net Margin7,35%
Op. Margin13,17%
Veiligheid
Debt / Equity
0,09
Current Ratio3,10
Interest Coverage95,69
Waardering
P/E Ratio
30,66
P/B Ratio3,11
EV/EBITDA15,36
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,38% | Revenue Growth (3Y) | -7,63% |
| Earnings Growth (1Y) | -15,92% | Earnings Growth (3Y) | -5,15% |
| Revenue Growth (5Y) | 0,83% | Earnings Growth (5Y) | -1,14% |
| Profitability | |||
| Revenue (TTM) | 590,63M | Net Income (TTM) | 43,40M |
| ROE | 10,68% | ROA | 6,91% |
| Gross Margin | 22,28% | Operating Margin | 13,17% |
| Net Margin | 7,35% | Free Cash Flow (TTM) | 73,61M |
| ROIC | 12,53% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 3,10 |
| Interest Coverage | 95,69 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 30,66 | P/B Ratio | 3,11 |
| P/S Ratio | 2,25 | PEG Ratio | -1,26 |
| EV/EBITDA | 15,36 | Dividend Yield | 0,02% |
| Market Cap | 1,33B | Enterprise Value | 1,19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 590,63M | 565,85M | 692,29M | 673,58M | 571,40M |
| Net Income | 43,40M | 51,61M | 48,24M | 55,11M | 45,44M |
| EPS (Diluted) | 0,54 | 0,63 | 0,59 | 0,69 | 0,57 |
| Gross Profit | 131,57M | 238,80M | 252,08M | 243,47M | 206,09M |
| Operating Income | 77,77M | 78,31M | 72,74M | 81,00M | 64,86M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 627,65M | 740,72M | 719,21M | 735,89M | 650,69M |
| Total Liabilities | 200,33M | 329,92M | 343,75M | 379,25M | 362,99M |
| Shareholders' Equity | 427,31M | 385,02M | 375,46M | 313,19M | 269,37M |
| Total Debt | 38,06M | 46,72M | 73,63M | 82,92M | 60,50M |
| Cash & Equivalents | 174,29M | 147,47M | 131,04M | 162,81M | 181,36M |
| Current Assets | 508,93M | 637,48M | 553,01M | 570,10M | 514,05M |
| Current Liabilities | 164,33M | 170,69M | 285,61M | 316,43M | 301,75M |